Navigation Links
Cephalon Submits New Drug Application for TREANDA for the Treatment of Chronic Lymphocytic Leukemia
Date:9/21/2007

FRAZER, Pa., Sept. 21 /PRNewswire-FirstCall/ -- Cephalon, Inc. (Nasdaq: CEPH) today announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) requesting approval of TREANDA(R) (bendamustine HCl) for the treatment of patients with chronic lymphocytic leukemia (CLL). CLL is a slowly progressing blood and bone marrow disease with an estimated 15,000 new cases diagnosed every year in the United States, according to the National Cancer Institute. If approved, TREANDA would be the first new therapy approved by the FDA for the treatment of CLL since 2001. In August 2007, the FDA granted orphan drug designation to TREANDA for this indication.

"This is our first regulatory filing for TREANDA and a significant milestone for our growing oncology portfolio," said Dr. Lesley Russell, Executive Vice President, Worldwide Medical and Regulatory Operations. "We also are developing TREANDA for the treatment of non-Hodgkin's lymphoma and are planning additional submissions for Cephalon oncology compounds to the FDA over the next 12 months."

The NDA is based on a large, international multi-center Phase 3 clinical trial that evaluated the safety and efficacy of bendamustine HCl, the active ingredient in TREANDA, compared to chlorambucil in patients who were not previously treated for their disease. Chlorambucil is an FDA-approved first- line therapy for patients with CLL. In the pivotal trial, bendamustine HCl met both primary endpoints, overall response and progression-free survival and demonstrated an acceptable tolerability profile. The company anticipates that results from this study will be released at the upcoming American Society of Hematology (ASH) annual meeting in December 2007.

The company also is studying TREANDA for the treatment of patients with indolent (or slowly-progressing) non-Hodgkin's lymphoma (NHL), who are refractory to the monoclonal antibody rituximab. Pending positive results from this o
'/>"/>

SOURCE Cephalon, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. A Versatile Power Supply for All Electrophoresis Applications
2. Highest Possible Transformation Efficiencies for High-Throughput Applications
3. Unique DNA Polymerase Formulation Excels in a Broad Range of PCR Applications
4. High-Throughput System Generates Ultra-Pure PCR Products Suitable for All Applications
5. An Assessment of the Eppendorf twin.tec plate performance in PCR* applications
6. Principles and applications of electrical cell fusion
7. Eppendorf Electroporation Application Notes Your participation is highly welcome !!!
8. Optimizing Büchi® Rotary Evaporator Applications
9. Principles and applications of electrical cell fusion
10. Eppendorf Electroporation Application Notes Your participation is highly welcome !!!
11. Optimizing Büchi® Rotary Evaporator Applications

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/5/2009)...wire/ -- The endangered black-footed ferrets inhab...e carnivore feeds on prairie dogs. The prairie d...e population die-offs in towns occur. The U.S. Fi...ferret breeding program and has been releasing tra...abitat. Unfortunately, plague can sweep through a...
(Date:11/5/2009)...irstCall/ -- Transgenomic, Inc. (OTC Bulletin Boar... quarter ended September 30, 2009. The Company,s f...follow. ,, Third Quarter 2009 ,, The Compa...are for the third quarter of 2009 as compared to a...hird quarter of 2008. ,, Net sales were $5.0 m...
(Date:11/5/2009)...re-FirstCall/ -- WaferGen Biosystems, Inc. (OTC Bu...of-the-art genetic analysis systems, today announc...mpany,s Scientific Advisory Board. His career has...el molecular diagnostics for cancer detection and ...utational biology systems for several biotechnolog...
(Date:11/5/2009)...s brings a new look to Pro Repro , ...rofessional Reprographics, Orange County’s f... present Brooke Sanders to the company. Brooke joi...e addition of Brooke to the company represents con...eprographics., , ,Brooke brings with her over five...
Breaking Biology Technology:Colorado Companies Team Up With U.S. Fish & Wildlife Service to Protect Black-Footed Ferret 2Transgenomic, Inc. Reports Third Quarter 2009 Results 2Transgenomic, Inc. Reports Third Quarter 2009 Results 3Transgenomic, Inc. Reports Third Quarter 2009 Results 4Transgenomic, Inc. Reports Third Quarter 2009 Results 5Transgenomic, Inc. Reports Third Quarter 2009 Results 6Transgenomic, Inc. Reports Third Quarter 2009 Results 7WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 2WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 3WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 4
...linary team of Cornell nanotechnology researchers ... material that holds promise for light-emitting, f...lved years of perfecting a technique for building ...ted in the Sept. 30 online publication of the jour...m had long studied the molecular semiconductor rut...
...ct. 9 Thermo Fisher,Scientific Inc. (NYSE: TMO )...nced it has acquired NanoDrop Technologies, LLC, a...visible (UV-Vis) instrumentation.,The acquisition ...s,spectrophotometry instruments for applications i...volume samples are used in emerging life,sciences ...
..., Oct. 9 Pharmaceutical and biotech,companies rea... they ensure,strong partnerships between R&D and m...mmercial focus in all stages of product developmen...that have traditionally,separated R&D from marketi...nted medical researchers and skillful marketers. ...
Other Biology Technology:CU researchers shed light on light-emitting nanodevice 2Thermo Fisher Scientific Acquires Leader in Micro-Volume Spectrophotometers, NanoDrop Technologies 2Thermo Fisher Scientific Acquires Leader in Micro-Volume Spectrophotometers, NanoDrop Technologies 3Pharmaceutical Product Launch: Commercially Focused R&D Increases Drug's Market Potential 2
(Date:11/8/2009)... a gene through deletion of genetic material on ch...lities in learning and behavior, said a consortium...( www.bcm.edu ) in a report that appears online to...search goes about 95 percent of the way to pinning... to this gene," said Dr. Arthur L. Beaudet ( http:...
(Date:11/6/2009)...mony with their arboreal hosts. But new research s...rees of choice, the ants can get destructive to ne...e November issue of the American Naturalist , is ...es, and it reopens a centuries-old debate on the r...certain species of plants and trees have cozy rela...
(Date:11/5/2009)...ersity have developed synthetic molecules capable ... HIV-infected cells, as well as to prostate cancer...ournal of the American Chemical Society , could le...ses. , The molecules called "antibody-recruiti...ecruiting molecule targeting prostate cancer" (ARM...
Breaking Biology News(10 mins):Developmental delay could stem from nicotinic receptor deletion 2Ants are friendly to some trees, but not others 2New synthetic molecules trigger immune response to HIV and prostate cancer 2Free Ask a Doctor Online Services Can Save Lives with Both Expert and Novice Input 48997 1Free Ask a Doctor Online Services Can Save Lives with Both Expert and Novice Input 48997 2Free Ask a Doctor Online Services Can Save Lives with Both Expert and Novice Input 48997 3DNA Diagnostics Center Offers Father 26apos 3Bs Day DNA Testing 12638 1DNA Diagnostics Center Offers Father 26apos 3Bs Day DNA Testing 12638 2Executive Shares His Story in an Effort to Save Lives 48994 1Executive Shares His Story in an Effort to Save Lives 48994 2
...lar biophysics and biochemistry at Yale has recei...dation to expand research on the delivery of a tar...les. , Garen and his collaborator Zhiwei Hu hav...he blood vessels of solid tumors, thus destroying ... , The technology uses a synthetic gene encoding...
... with a drug compound substantially improved learn..., say researchers at the Stanford University Schoo...al. What’s more, the gains lasted for months after...re now considering a clinical trial to test whethe... Down syndrome. , "This treatment has remarkable p...
...uld help control weight, lower fat and cholesterol...ports Lisa Richards in Chemistry & Industry, t...been hailed for its cholesterol lowering capabilit...nufacturer Birds Eye has added the beans to its ra...wn that black soya may be even more potent in rats...
Other Biology News:Nanoparticles for delivery of prostate cancer treatment 2Drug treatment improves learning in mice with Down syndrome symptoms, Stanford/Packard study shows 2Drug treatment improves learning in mice with Down syndrome symptoms, Stanford/Packard study shows 3Drug treatment improves learning in mice with Down syndrome symptoms, Stanford/Packard study shows 4
...ilZyme AP Conjugate Stabilizer is an aqueous solut...her non-toxic stabilizing chemicals in a MES buffe... This product contains a combination of 0.02% met...preservative. StabilZyme AP Conjugate Stabilizer ...
Mouse Anti-Myoglobin Monoclonal Antibody, Biotin Conjugated, Clone 4E2 from Meridian Life Science, Inc.
... nonspecific binding is a problem in your applicat...vidin products as superior alternatives to avidin ...derivative that combines several key features to p... low nonspecific binding properties. NeutrAvidin d...
BlueView Nucleic Acid Stain from Sigma-Aldrich
Biology Products: